Open Access News

News from the open access movement


Monday, June 13, 2005

More on ACS v. PubChem

Aliya Sternstein, Publishers make appeal to lawmakers in NIH dispute, Federal Computer Week, June 13, 2005. Excerpt: 'American Chemical Society officials are asking lawmakers to rein in those responsible for a federal database of molecular structures because they say it will cut into the society's income from the sale of similar information. The National Institutes of Health created PubChem in 2004 as part of NIH's Roadmap for Medical Research initiative to speed the discovery of new medical treatments....Brian Dougherty, senior adviser to the chief strategy officer at ACS, said the society suggested forming a technical working group to set parameters for PubChem. "NIH has been unwilling to put anything in writing," Dougherty said. "We think this is going to put us out of business if it keeps growing and no parameters are set." NIH officials said they are confused about why ACS insists that PubChem will harm the society's business interests. "What is in common is a relatively small number of compound structures and names," said Christopher Austin, senior adviser to the translational research director at the NIH Chemical Genomics Center at the National Human Genome Research Institute. "ACS has gotten hung up on this," he said. "CAS has 25 million structures. PubChem has about 850,000. PubChem is a subset. Not everything that is in CAS is relevant to biomedical research." NIH officials said narrowing PubChem's focus could slow medical progress. "It would have profoundly negative effects on this new paradigm of making medical discoveries," Austin said.'